Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

INTERVIEW: Collaboration Key For China Regulatory Reforms, RDPAC Says (Part 1)

This article was originally published in PharmAsia News

Executive Summary

The days when foreign investments were welcomed with open arms in China seem to be gone, and a toughening environment is setting in. As the head of the top multinational research-based pharma association in the country, RDPAC managing director Joseph Cho is looking to local partnerships to help pursue regulatory reforms and expand new drug access in a rapidly changing market.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC088868

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel